Aurora kinases A and B and familial breast cancer risk

被引：47

作者：

Tchatchou, Sandrine ^{[1
]}

Wirtenberger, Michael

Hemminki, Kari

Sutter, Christian

Meindl, Alfons

Wappenschmidt, Barbara

Kiechle, Marion

Bugert, Peter

Schmutzler, Rita K.

Bartram, Claus R.

Burwinkel, Barbara

机构：

[1] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany

[2] Karolinska Inst, Novum, Dept Biosci, Huddinge, Sweden

[3] Heidelberg Univ, Inst Human Genet, Heidelberg, Germany

[4] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynaecol, D-8000 Munich, Germany

[5] Univ Cologne, Div Mol Gynaeco Oncol, Dept Obstet & Gynaecol, Ctr Clin, Cologne, Germany

[6] Univ Hosp Cologne, Ctr Mol Med Cologne, Cologne, Germany

[7] Heidelberg Univ, Fac Clin Med, Inst Transfus Med & Immunol, Red Cross Blood Serv Baden Wurttemberg Hessia, D-6800 Mannheim, Germany

[8] Helmholtz Univ, Grp Mol Epidemiol, German Canc Res Ctr, Heidelberg, Germany

来源：

CANCER LETTERS | 2007年 / 247卷 / 02期

关键词：

breast cancer; case-control study; aurora kinases; polymorphism;

D O I：

10.1016/j.canlet.2006.05.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Aurora genes play a crucial role in tumourigenesis and are overexpressed in many kinds of cancers. We investigated whether coding variants within the Aurora genes are associated with familial breast cancer risk. While AURKA Phe31Ile (1712T > A) and AURKB Thr298Met (893G > A) showed no association, the synonymous AURKB Ser295Ser (885A > G) polymorphism resulted in an increased breast cancer risk for carriers of the homozygous 885G genotype (OR = 1.45, 95% CI = 1.05-2.0, P = 0.02). Due to the impact of aurora kinases in the loss of chromosomal integrity during carcinogenesis, this variant may also influence the therapy outcome in breast cancer. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

引用

页码：266 / 272

页数：7

共 50 条

[41] Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
S A Hartsink-Segers
C M Zwaan
C Exalto
M W J Luijendijk
V S Calvert
E F Petricoin
W E Evans
D Reinhardt
V de Haas
M Hedtjärn
B R Hansen
T Koch
H N Caron
R Pieters
M L Den Boer
Leukemia, 2013, 27 : 560 - 568
[42] Oral contraceptives and risk of familial breast cancer
Heimdal, K
Skovlund, E
Moller, P
CANCER DETECTION AND PREVENTION, 2002, 26 (01): : 23 - 27
[43] Risk for familial breast cancer increases with age
Hemminki, K
Granström, C
NATURE GENETICS, 2002, 32 (02) : 233 - 233
[44] Risk for familial breast cancer increases with age
Kari Hemminki
Charlotta Granström
Nature Genetics, 2002, 32 : 233 - 233
[45] The evaluation of women with familial risk of breast cancer
Boetes, C
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (03) : 97 - 101
[46] FAMILIAL RISK OF BREAST-CANCER AND ABORTION
ANDRIEU, N
CLAVEL, F
GAIRARD, B
PIANA, L
BREMOND, A
LANSAC, J
FLAMANT, R
RENAUD, R
CANCER DETECTION AND PREVENTION, 1994, 18 (01): : 51 - 55
[47] FAMILIAL HISTORY AND RISK OF BREAST-CANCER
SPEIZER, FE
HENNEKENS, CH
ROSNER, B
BAIN, C
BELANGER, C
CLINICAL RESEARCH, 1978, 26 (03): : A282 - A282
[48] Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer
Gully, Christopher
Chen, Jian
Zhang, Fanmao
Yeung, James
Yeung, Sai-Ching Jim
Lee, Mong-Hong
CANCER RESEARCH, 2009, 69
[49] Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer
Gully, Christopher P.
Zhang, Fanmao
Chen, Jian
Yeung, James A.
Velazquez-Torres, Guermarie
Wang, Edward
Yeung, Sai-Ching Jim
Lee, Mong-Hong
MOLECULAR CANCER, 2010, 9
[50] Risk models for familial ovarian and breast cancer
Antoniou, AC
Gayther, SA
Stratton, JF
Ponder, BAJ
Easton, DF
GENETIC EPIDEMIOLOGY, 2000, 18 (02) : 173 - 190

← 1 2 3 4 5 →